Literature DB >> 7429501

Early pulmonary vascular changes in congenital heart disease studied in biopsy tissue.

M Rabinovitch, S G Haworth, Z Vance, G Vawter, A R Castaneda, A S Nadas, L M Reid.   

Abstract

Patients with congenital heart defects who had or were at risk for developing pulmonary artery hypertension underwent lung biopsy at the time of intracardiac repair. In 95 consecutive patients with either ventricular septal defect, d-transposition of the great arteries, or a defect of the atrioventricular canal, the pulmonary arteries were evaluated microscopically by quantitative morphologic techniques, and the findings were correlated with hemodynamic data obtained at a recent preoperative cardiac catheterization. Three grades of severity of early pulmonary vascular changes were identified, which correlated with hemodynamic evidence of progressive functional impairment. Grade A denotes cases with abnormal extension of muscle into peripheral arteries only; pulmonary blood flow is increased but pulmonary artery pressure is normal. In grade B an increased medial wall thickness of the normally muscular arteries is also present, and in these cases pulmonary artery pressure is also increased. Grade C denotes cases in which in addition to the findings in grade B disease there is a reduction in the number of small peripheral arteries; in these cases pulmonary vascular resistance is increased. Follow-up postoperative hemodynamic evaluation will reveal the significance of these changes in reflecting irreversible functional impairment of the pulmonary vascular bed.

Entities:  

Mesh:

Year:  1980        PMID: 7429501

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  The radial alveolar count method of Emery and Mithal: a reappraisal 1--postnatal lung growth.

Authors:  T P Cooney; W M Thurlbeck
Journal:  Thorax       Date:  1982-08       Impact factor: 9.139

Review 2.  Molecular pathogenesis and current pathology of pulmonary hypertension.

Authors:  Vinicio A de Jesus Perez
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

3.  Early-lethal Costello syndrome due to rare HRAS Tandem Base substitution (c.35_36GC>AA; p.G12E)-associated pulmonary vascular disease.

Authors:  K Nicole Weaver; Dehua Wang; James Cnota; Nicholas Gardner; Deborah Stabley; Katia Sol-Church; Karen W Gripp; David P Witte; Kevin E Bove; Robert J Hopkin
Journal:  Pediatr Dev Pathol       Date:  2014-08-18

4.  Study of Pulmonary Arterial Pressures and Histopathological Changes in Patients Having Congenital Heart Defects with Left-to-Right Shunt.

Authors:  Srikrishna Modugula Reddy; Shyam Kumar S Thingnam; Kusum Joshi
Journal:  Indian J Surg       Date:  2010-11-25       Impact factor: 0.656

5.  Failure to show decrease in small pulmonary blood vessels in rats with experimental pulmonary hypertension.

Authors:  J M Kay; K L Suyama; P M Keane
Journal:  Thorax       Date:  1982-12       Impact factor: 9.139

6.  Pulmonary arterial changes in patients with ventricular septal defects and severe pulmonary hypertension.

Authors:  R Fried; G Falkovsky; J Newburger; A I Gorchakova; M Rabinovitch; M I Gordonova; D Fyler; L Reid; V Burakovsky
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

7.  Pulmonary vascular structure in patients dying after a Fontan procedure. The lung as a risk factor.

Authors:  E Juaneda; S G Haworth
Journal:  Br Heart J       Date:  1984-11

8.  [Fatal lung hemorrhage in complex pulmonary angiodysplasia in a case of mongolism].

Authors:  S Ogbuihi; P Zink
Journal:  Z Rechtsmed       Date:  1988

Review 9.  Focused Update on Pulmonary Hypertension in Children-Selected Topics of Interest for the Adult Cardiologist.

Authors:  Sulaima Albinni; Manfred Marx; Irene M Lang
Journal:  Medicina (Kaunas)       Date:  2020-08-19       Impact factor: 2.430

10.  Segmental Pulmonary Hypertension in Children with Congenital Heart Disease.

Authors:  Bibhuti B Das; Benjamin Frank; Dunbar Ivy
Journal:  Medicina (Kaunas)       Date:  2020-09-24       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.